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PBE0Abstract Density-functional theory (DFT) is a prevailing method for predicting the geometry of
organic compounds. The ground state geometries have been calculated at the B3LYP/6-31G**
and PBE0/6-31G** levels of theories. The excited state geometries have been computed at time
dependent DFT (TD-DFT) by using TD-B3LYP/6-31G** and TD-PBE0/6-31G** levels of theories.
It has been revealed that the PBE0 functional is better than B3LYP to predict the S–O and S–C
bond lengths. Both of the functionals could not reproduce the S–N bond lengths. The B3LYP is
good to imitate the C–N and C–O bond lengths. The C–C and C–Cl bond lengths have been imper-
sonated by both the functionals. Moreover, it has also been revealed that the S–N bond length elon-
gated while the C–N bond length shortened from ground to excited state.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Malignant tumor, i.e., cancer is a dreadful menace to human
beings (Ye et al., 1999). The progress of potential and effective
anticancer drugs has become one of the most intensely per-
suaded goals of contemporary medicinal chemistry. The role
of schiff bases as intermediate products in biologically impor-
tant reactions is well known (Rozwadowski et al., 2005).Benzothiazines ﬁnd a number of applications in pharmaceuti-
cal chemistry (Gupta et al., 1985, 1993, 2002; Lombardino and
Wiseman, 1972). The benzisothiazol derivatives are also excel-
lent antimycobacterial and antitumor compounds.
There is no systematic structural study on 2H-1,2-benzothi-
azine-3-carboxylic acid, 4-hydroxy-2-(2-oxopropyl)-methyl ester,
1,1-dioxide (drug 1) which has been derived from benzothiazine
of Chiaini et al. (1971) and Lorenzo et al. (1994), 2-[2-(3-chloro-
phenyl)-2-oxoethyl]-1,2-benzisothiazol-3(2H)-one 1,1-dioxide
(drug 2) (Khalid et al., 2010a,b) and (3-chlorophenyl)(4-hydro-
xy-1,1-dioxido-2H-1,2-benzothiazine-3-yl)methanone (drug 3)
(Khalid et al., 2010a,b, p. o885), see Fig. 1.
The PBE1PBE (also called PBE0) functional has been rec-
ognized to provide reliable predictions and interpretations of
the molecular geometries for sulfur compounds in good agree-
ment with experimental data for organic molecules bearing
drug 1     drug 2      drug 3 
Figure 1 Investigated drugs in the present study.
Table 1 Bond lengths (A˚) and bond angles (degree) of drug 1
at B3LYP/6-31G** and PBE0/6-31G** levels of theories.
B3LYPa PBE0b Exp B3LYPc PBE0d
Bond lengths
S0–O1 1.469 1.453 1.434 1.469 1.469
C16–O4 1.239 1.235 1.230 1.253 1.253
C17–O5 1.440 1.429 1.452 1.436 1.436
C14–O3 1.333 1.323 1.345 1.326 1.326
C19–O6 1.214 1.210 1.212 1.202 1.202
C16–O5 1.343 1.334 1.325 1.360 1.360
S0–N7 1.690 1.672 1.634 1.781 1.781
S0–C8 1.784 1.769 1.757 1.763 1.763
C15–N7 1.424 1.416 1.434 1.399 1.399
C18–N7 1.461 1.450 1.473 1.416 1.417
Bond angles
O1–S0–O2 120.62 120.83 119.25 120.20 120.20
N7–S0–C8 100.56 100.71 102.07 98.83 98.83
S0–N7–C15 115.50 115.33 114.91 117.33 117.33
C15–N7–C18 120.89 120.69 119.38 123.56 123.56
S0–C8–C9 120.06 120.22 121.43 118.01 118.02
S0–C8–C13 117.91 117.81 116.52 119.45 119.44
N7–C15–C14 121.46 121.64 120.99 115.52 115.52
N7–C18–C19 115.35 114.98 114.36 113.55 113.55
O3–C14–C15 122.50 122.54 123.04 118.07 118.07
O3–C14–C13 114.78 115.12 113.34 118.11 118.10
O6–C19–C18 121.96 121.75 121.98 121.96 121.75
O6–C19–C20 122.57 122.75 122.74 122.57 122.75
C17–O5–C16 115.62 115.20 115.78 115.62 115.20
O4–C16–O5 121.79 121.87 123.75 121.78 121.87
O5–C16–C15 114.78 114.79 113.78 114.78 114.79
Exp = experimental data at ground state (Chiaini et al., 1971;
Lorenzo et al., 1994).
ab Ground state.
cd Excited state.
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quemin and Perpe`te, 2006). In the present study we have shed
light on the ground and excited state geometries of the selected
compounds. We pointed out which functional B3LYP or
PBE0 is good to predict the C–S, O–S, N–S, C–N and C–O
bond lengths as well as the bond angles that originated from
the C, N, O and S elements.
2. Computational details
It is well reported that the density-functional theory (DFT) is a
useful method for the investigation of the geometries of mole-
cules (Scott andRadom, 1996; Irfan et al., 2009; Jacob andFisc-
ker, 2002; Andersen et al., 1999; Song et al., 2005). The ground
state geometry optimizations were performed with Becke–Lee–
Yang–Parr’s three-parameter hybrid functional (B3LYP)
(Becke, 1993) and PBE0 (Perdew et al., 1996, 1997; Adamo
and Barone, 1999) with 6-31G** basic set (Hehre et al., 1986).
All calculations were performed with the Gaussian 09W pro-
gram suit (Frisch, 2009). The excited state geometries have been
computed by time dependent DFT (TD-DFT) (Bauernschmitt
and Ahlrichs, 1996; Casida et al., 1998; Stratmann et al.,
1998; Scalmani et al., 2006; Furche and Ahlrichs, 2002) by using
TD-B3LYP/6-31G** and TD-PBE0/6-31G** levels of theories.
3. Results and discussion
3.1. Geometries
The bond lengths and bond angles of drug 1 have been pre-
sented in Table 1 along with the experimental data of ground
state geometry. B3LYP and PBE0 overestimate the S0–O1
0.035, 0.019 A˚, S0–N7 0.056, 0.038 A˚, S0–C8 0.027 and
0.012 A˚, respectively, compared to experimental data (Chiaini
et al., 1971; Lorenzo et al., 1994). B3LYP and PBE0 underesti-
mate the C17–O5 0.012, 0.023 A˚, C14–O3 0.012 and 0.022 A˚,
respectively. B3LYP and PBE0 underestimate the C15–N7,
0.010, 0.018 A˚, C18–N7 0.012 and 0.023 A˚, respectively. The ex-
cited state bond lengths are analogous at both the levels of
B3LYP and PBE0. Generally, C16–O4, C16–O5, and S0–N7 ex-
cited state bond lengths are elongated to 0.014, 0.017, and
0.091 A˚, respectively, while C19–O6, C15–N7, and C18–N7 short-
ened to 0.012, 0.025, 0.046 A˚, respectively, at B3LYP/6-31G**
level of theory. The S0–O1, C16–O4, C16–O5, and S0–N7 excited
state bond lengths are elongated to 0.016, 0.018, 0.026,
and 0.109 A˚, respectively, while C19–O6, C15–N7, and C18–N7shortened to 0.008, 0.017, 0.033 A˚, respectively, at PBE0/6-
31G** level of theory.
All the angles O–S–O, N–S–C, N–C–C, O–C–C, O–C–O,
and S–C–C deviate by <2 compared to experimental data
computed at B3LYP/6-31G** and PBE0/6-31G** levels of theo-
ries which disclosed that both of the levels are good to repro-
duce the bond angles. The excited state bond angles of
C15–N7–C18 and O3–C14–C13 are 2.67 and 3.33 larger, respec-
tively, compared to ground state. The excited state bond angles
of S0–C8–C9, N7–C15–C14, andO3–C14–C15 are 2.05, 5.94, and
4.43 smaller, respectively, compared to ground state at
Table 3 Bond lengths (A˚) and bond angles (degree) of drug 3
at B3LYP/6-31G** and PBE0/6-31G** levels of theories.
B3LYPa PBE0b Exp B3LYPc PBE0d
Bond lengths
S1–O2 1.462 1.454 1.424 1.459 1.460
C15–O5 1.257 1.252 1.250 1.273 1.275
C13–O4 1.322 1.312 1.327 1.334 1.336
Cl0–C18 1.759 1.739 1.739 1.766 1.766
S1–N6 1.681 1.664 1.604 1.759 1.759
S1–C7 1.788 1.780 1.747 1.781 1.782
C14–N6 1.431 1.436 1.422 1.341 1. 342
Bond angles
O2–S1–O3 121.52 121.65 118.25 120.85 120.86
N6–S1–C7 100.59 100.66 101.04 98.61 98.61
S1–N6–C14 117.62 117.25 119.33 125.03 125.05
S1–C7–C12 118.42 118.35 117.44 120.61 120.61
O2-S1-N6 106.79 106.90 108.38 105.11 105.11
O3–S1–C7 108.72 108.63 106.32 110.36 110.36
N6–C14–C15 120.49 120.87 120.78 119.02 119.00
N6–C14–C13 120.23 120.35 118.69 121.34 121.36
O5–C15–C16 117.99 118.12 117.93 129.91 129.91
O5–C15–C14 119.32 119.37 119.18 107.60 107.61
O4–C13–C14 121.79 121.80 122.35 116.26 116.26
O4–C13–C12 115.34 115.76 115.07 119.86 119.86
Cl0–C18–C19 119.34 119.42 119.31 118.27 118.27
Cl0–C18–C17 119.40 119.49 119.03 119.11 119.12




Table 2 Bond lengths (A˚) and bond angles (degree) of drug 2
at B3LYP/6-31G** and PBE0/6-31G** levels of theories.
B3LYPa PBE0b Exp B3LYPc PBE0d
Bond lengths
S1–O3 1.462 1.453 1.428 1.461 1.460
C15–O5 1.215 1.211 1.206 1.288 1.288
C13–O2 1.216 1.211 1.207 1.219 1.217
N6–C13 1.394 1.388 1.387 1.395 1.395
S1–N6 1.728 1.708 1.671 1.742 1.743
S1–C7 1.786 1.772 1.755 1.787 1.787
N6–C14 1.446 1.436 1.456 1.445 1.445
C18–Cl0 1.757 1.738 1.740 1.764 1.764
Bond angles
O4–S1–O3 118.99 119.01 117.00 119.84 119.84
N6–S1–C7 91.20 91.42 92.64 90.90 90.90
S1–N6–C13 115.19 115.47 115.43 114.89 114.89
C14–N6–C13 121.96 121.59 122.70 121.89 121.88
S1–C7–C8 126.88 126.95 127.13 126.61 126.60
S1–C7–C12 110.51 110.50 109.90 110.80 110.80
N6–C14–C15 112.16 111.74 111.71 114.02 114.01
N6–C13–C12 109.05 108.83 108.81 109.29 109.29
O3–S1–C7 112.66 112.77 112.54 111.88 111.87
O4–S1–N7 110.09 109.85 108.98 108.19 108.18
O2–C13–C12 126.92 127.13 127.45 127.32 127.32
O2–C13–N6 124.02 124.02 123.68 123.38 123.38
O5–C15–C16 121.67 121.69 121.92 124.86 124.86
O5–C15–C14 120.28 120.30 120.69 110.86 110.87
Cl0–C18–C17 119.26 119.34 119.19 118.67 118.66
Cl0–C18–C19 119.45 119.52 118.06 118.63 118.63
Exp = experimental data at ground state (Khalid et al., 2010a,b).
ab Ground state.
cd Excited state.
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of C15–N7–C18 and O3–C14–C13 are 2.87 and 2.99 larger,
respectively, compared to ground state. The excited state bond
angles of S0–C8–C9, N7–C15–C14, and O3–C14–C15 are 2.20,
6.12, and 4.47 smaller, respectively, compared to ground state
at PBE0/6-31G** level of theory.
The experimental and computed bond lengths and bond an-
gles of drug 2 have been tabulated in Table 2. B3LYP (PBE0)
overestimate the S1–O3, S1–N6, S1–C7 and C18–Cl0 as 0.034 A˚
(0.025 A˚), 0.057 A˚ (0.034 A˚), 0.031 A˚ (0.017 A˚) and 0.017 A˚,
respectively, compared to experimental geometries (Khalid et
al., 2010a,b). B3LYP and PBE0 underestimate the N6–C14, as
0.010 and 0.020 A˚, respectively. The excited state bond lengths
are analogous at both the levels. Generally, C15–O5, and S1–N6
of excited state bond lengths are elongated to 0.073 and 0.014 A˚,
respectively, at B3LYP/6-31G** level of theory. The C15–O5,
S1–N6, S1–N6, and C18–Cl0 of excited state bond lengths are
elongated to 0.077, 0.035, 0.015, and 0.026 A˚, respectively, at
PBE0/6-31G** level of theory.
We have observed that all the angles, i.e., O–S–O, N–S–C,
N–C–C, O–C–C, O–C–O, S–C–C and Cl–C–C are in good
agreement with experimental data. The excited state bond an-
gle of O5–C15–C16 is almost 3.19 larger while O5–C15–C14 is
9.42 smaller than the ground state at both the levels of
theories.
In Table 3, we have tabulated the experimental and com-
puted bond lengths and bond angles of drug 3. B3LYP overes-
timate the S1–O2, C18–Cl0, S1–N6, and S1–C7 as 0.038, 0.020,0.077 and 0.041 A˚, respectively, compared to experimental
bond lengths (Khalid et al., 2010a,b, p. o885). PBE0 overesti-
mate the S1–O2, S1–N6, and S1–C7 as 0.030, 0.060, and
0.033 A˚, respectively, compared to experimental data. PBE0
underestimate the C13–O4, as 0.015 A˚. Usually, C15–O5, and
S1–N6 of excited state bond lengths are elongated to 0.016
and 0.078 A˚, respectively, while C14–N6 shortened to 0.09 A˚
compared to ground state at B3LYP/6-31G** level of theory.
C15–O5, C13–O, C18–Cl0 and S1–N6 of excited state bond
lengths are elongated to 0.023, 0.020, 0.027 and 0.095 A˚,
respectively, while C14–N6 shortened to 0.094 A˚ compared to
ground state at PBE0/6-31G** level of theory.
We noticed that B3LYP and PBE0 overestimate bond an-
gles, i.e., O1–S1–O2 and O3–S1–C7 as 3.27 and 2.40, respec-
tively. The excited state bond angles of S1–N6–C14, S1–C7–
C12, O5–C15–C16, and O4–C13–C12, are almost 7.41, 2.19,
11.92, and 4.52 larger while O5–C15–C14 and O4–C13–C14
are 11.72 and 5.53 smaller, respectively, than the ground
state at the B3LYP/6-31G** and PBE0/6-31G** levels of
theories.
We have observed that B3LYP is not good to predict the S–
O, S–N and S–C bond lengths while PBE0 is reliable to envis-
age the S–O and S–C bond lengths up to some extent. It was
also revealed that B3LYP is good to reproduce the C–N and
C–O bond lengths. Both the functionals are good to predict
C–C and C–Cl bond lengths. B3LYP would be a better choice
if investigated compounds have C–N, C–O, C–C or C–Cl. But
selection of PBE0 to expect the S–O and S–C might be good
but not for all the cases. Both of the functionals are not reliable
to imitate S–N experimental data. Moreover, it has also been
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length shortened from ground to excited state. In the excited
state, a major change in O–C–C bond angles toward superior
or inferior has been observed compared to the ground state
especially with the carbonyl angles.
4. Conclusions
In the framework of our present theoretical investigation, we
can draw the following conclusions:
(a) B3LYP is not good to predict the S–O, S–N and S–C
bond lengths while PBE0 is reliable to envisage the S–
O and S–C bond lengths.
(b) The S–N bond length elongated while the C–N bond
length shortened from ground to excited state.
(c) In the excited state, a major change in O–C–C bond
angles toward superior or inferior has been observed
compared to the ground state especially with the car-
bonyl angles.
(d) B3LYP is good to reproduce the C–N and C–O bond
lengths.
(e) Both the functionals are good to predict C–C and C–Cl
bond lengths.
(f) B3LYP would be a better choice if investigated com-
pounds have C–N, C–O, C–C or C–Cl but selection of
PBE0 is expected to predict S–O and S–C in a reason-
able manner but not for all the cases.
(g) Both of the functionals are not reliable to imitate S–N
experimental data.Acknowledgment
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